Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Bridgewater Associates, Winton Capital, Heron Therapeutics Inc (HRTX), Accuray Incorporated (ARAY), and More

Hedge Funds Bridgewater, Winton Register to Launch Products in China (Reuters)
SHANGHAI (Reuters) – Renowned global hedge fund managers Bridgewater Associates LP and Winton Group Ltd have had registrations to launch products in China accepted at a time of turbulence in capital markets, reflecting a change in the government’s stance toward such foreign funds. The Shanghai subsidiaries of Bridgewater and Winton both registered at the Asset Management Association of China (AMAC) on June 29, showed notices posted on the association’s website on Tuesday, paving way for private fund launches in the country. According to rules, asset managers must launch products within six months of registration.

Former Perry Exec Uziel Back in Business (HFAlert.com)
Former Perry Capital partner Ori Uziel is returning to the hedge fund business after a 10-year absence. Uziel, who retired from Perry at yearend 2007 when he was just 36 years old, opened a firm in New York last year called Uziel Capital. Now he’s getting ready to launch a hedge fund called Vista Grande Partners, which is scheduled to begin trading in August with about $10 million of friends-and-family money. Next year, Uziel plans to market the vehicle to a wider audience. The fund will pursue a special-situations strategy that Uziel has been running in separate accounts since May 2017.

Wall Street Stocks Market Insider Trading

Rawpixel / shutterstock.com

Hedge Fund Plays Trade Spat Shorting China Cars, Buying Travel (Bloomberg)
The escalating trade dispute between China and the U.S. prompted hedge fund manager Pinpoint Asset Management to take money off the table earlier this year. It’s now game-planning for a potential agreement between the world’s top two economies. “The likely scenario to result from the China-U.S. trade tensions would be a trade deal — largely due to China conceding,” said Jennifer Wong, managing director of investor relations at Pinpoint Asset Management, which manages $3.6 billion in long-short equity and multi-strategy hedge funds focused on Asia.

China Hedge Fund Says Stocks Are Near Bottom (Bloomberg)
The rout in Chinese stocks may be nearing an end as the central bank turns to more accommodative monetary tools, according to Shanghai Chongyang Investment Management Co., whose flagship hedge fund has returned 356 percent since its launch in September 2008. “While asset prices will face a ceiling given China’s tough regulation, risk prevention and deleveraging, a more flexible policy stance will put a floor under risk asset prices,” said President Wang Qing. “The market clearly is in its bottom range after earlier corrections.”

Insider Selling: Heron Therapeutics Inc (HRTX) President Sells 225,000 Shares of Stock (MareaInformativa.com)
Heron Therapeutics Inc (NASDAQ:HRTX) President Robert Rosen sold 225,000 shares of the company’s stock in a transaction dated Monday, July 2nd. The stock was sold at an average price of $38.98, for a total value of $8,770,500.00. Following the completion of the transaction, the president now directly owns 132,109 shares in the company, valued at $5,149,608.82. The sale was disclosed in a filing with the SEC.

Insider Selling: Accuray Incorporated (ARAY) CEO Sells 34,235 Shares of Stock (MareaInformativa.com)
Accuray Incorporated (NASDAQ:ARAY) CEO Joshua Levine sold 34,235 shares of the business’s stock in a transaction that occurred on Tuesday, July 3rd. The stock was sold at an average price of $4.08, for a total value of $139,678.80. Following the completion of the transaction, the chief executive officer now owns 1,392,518 shares in the company.

Insider Selling: Evolution Petroleum Corp (EPM) CFO Sells 16,000 Shares of Stock (WeekHerald.com)
Evolution Petroleum Corp (NYSEAMERICAN:EPM) CFO David Joe sold 16,000 shares of the stock in a transaction on Monday, July 2nd. The stock was sold at an average price of $11.02, for a total value of $176,320.00. Following the completion of the sale, the chief financial officer now directly owns 277,590 shares in the company, valued at $3,059,041.80. The transaction was disclosed in a filing with the Securities & Exchange Commission.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.